NCT00318669View on ClinicalTrials.gov

Social Anxiety Disorder Study Of Paroxetine

PHASE3CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Social Phobia
Interventions
DRUG

Paroxetine hydrochloride hydrate

Trial Locations (16)

802-0006

GSK Investigational Site, Fukuoka

810-0001

GSK Investigational Site, Fukuoka

815-0041

GSK Investigational Site, Fukuoka

332-0012

GSK Investigational Site, Saitama

107-0062

GSK Investigational Site, Tokyo

120-0033

GSK Investigational Site, Tokyo

143-8541

GSK Investigational Site, Tokyo

144-0052

GSK Investigational Site, Tokyo

152-0012

GSK Investigational Site, Tokyo

154-0004

GSK Investigational Site, Tokyo

160-0023

GSK Investigational Site, Tokyo

170-0002

GSK Investigational Site, Tokyo

170-0005

GSK Investigational Site, Tokyo

178-0063

GSK Investigational Site, Tokyo

194-0022

GSK Investigational Site, Tokyo

Unknown

GSK Investigational Site

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY